Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results

Background: BNT162b2 and mRNA-1273 are the two recently approved mRNA-based vaccines against COVID-19 which has shown excellent safety and efficacy. Preliminary data about specific and neutralizing antibodies is available covering the first 100 days after vaccination. Methods: We reviewed all the pu...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Frontiers in immunology Ročník 12; s. 657711
Hlavní autoři:	Lombardi, Andrea, Bozzi, Giorgio, Ungaro, Riccardo, Villa, Simone, Castelli, Valeria, Mangioni, Davide, Muscatello, Antonio, Gori, Andrea, Bandera, Alessandra
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland Frontiers Media S.A 12.03.2021
Témata:	2019-nCoV Vaccine mRNA-1273 Animals antibodies Antibodies, Neutralizing - blood Antibodies, Viral - blood BNT162 Vaccine COVID-19 COVID-19 - blood COVID-19 - immunology COVID-19 - prevention & control COVID-19 - virology COVID-19 Vaccines - adverse effects COVID-19 Vaccines - therapeutic use CTL Diffusion of Innovation Host-Pathogen Interactions Humans Immunization Immunogenicity, Vaccine Immunology mRNA Vaccines neutralization test RNA vaccine SARS-CoV-2 SARS-CoV-2 - genetics SARS-CoV-2 - immunology Treatment Outcome Vaccines, Synthetic - adverse effects Vaccines, Synthetic - therapeutic use COVID-19 SARS-CoV-2 CTL antibodies RNA vaccine neutralization test
ISSN:	1664-3224, 1664-3224
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!